Nucleic Acids Research, 1994, Vol. 22, No. 17 3511-3533
© 1994
Articles |
Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene, second edition
Haemostasis Research Group, Clinical Sciences Centre, Royal Postgraduate Medical School, Hammersmith Hospital Du Cane Road, London W12 ONN 1 Charter Molecular Genetics Laboratory, Thrombosis Research Institute Manresa Road, London SW3 6LR, UK 2 Department of Medicine and Howard Hughes Medical Institute, University of California San Francisco 3 Johns Hopkins University Baltimore 4 American Red Cross, Rockville, USA 5 Nara Medical College Kashihara City, Nara, Japan 6 Royal Hallamshire Hospital Sheffield, UK 7 Institut für Klinische Biochemie der Universität Bonn, Germany 8 Hôpital de Bicêtre Le Kremlin-Bicêtre, France 9 Guy's Hospital London 10 Department of Medical Genetics, Duncan Guthrie Institute Yorkhill, Glasgow G3 8SJ, UK
* To whom correspondence should be addressed
A large number of different mutations in the factor VIII (F8) gene have been identified as a cause of haemophilia A. This compilation lists known single base-pair substitutions, deletions and insertions in the F8 gene and reviews the status of the inversional events which account for a substantial proportion of mutations causing severe haemophilia A.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. Kubisz, J. Stasko, M. Dobrotova, J. Ivankova, and D. Mesko Severe Hemophilia and Physiologic Inhibitors of Coagulation Clinical and Applied Thrombosis/Hemostasis, July 1, 2005; 11(3): 331 - 334. [Abstract] [PDF] |
||||
![]() |
U. Hedner, D. Ginsburg, J. M. Lusher, and K. A. High Congenital Hemorrhagic Disorders: New Insights into the Pathophysiology and Treatment of Hemophilia Hematology, January 1, 2000; 2000(1): 241 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nogami, M. Shima, K. Hosokawa, T. Suzuki, T. Koide, E. L. Saenko, D. Scandella, M. Shibata, S. Kamisue, I. Tanaka, et al. Role of Factor VIII C2 Domain in Factor VIII Binding to Factor Xa J. Biol. Chem., October 22, 1999; 274(43): 31000 - 31007. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Fay and D. Scandella Human Inhibitor Antibodies Specific for the Factor VIII A2 Domain Disrupt the Interaction between the Subunit and Factor IXa J. Biol. Chem., October 15, 1999; 274(42): 29826 - 29830. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mazzarella and D. Schlessinger Pathological Consequences of Sequence Duplications in the Human Genome Genome Res., October 1, 1998; 8(10): 1007 - 1021. [Abstract] [Full Text] |
||||
![]() |
M. G. Jacquemin, B. G. Desqueper, A. Benhida, L. Vander Elst, M. F. Hoylaerts, M. Bakkus, K. Thielemans, J. Arnout, K. Peerlinck, J. G. G. Gilles, et al. Mechanism and Kinetics of Factor VIII Inactivation: Study With an IgG4 Monoclonal Antibody Derived From a Hemophilia A Patient With Inhibitor Blood, July 15, 1998; 92(2): 496 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fijnvandraat, E. A.M. Turenhout, E. N. van den Brink, J. W. ten Cate, J. A. van Mourik, M. Peters, and J. Voorberg The Missense Mutation Arg593 right-arrow Cys Is Related to Antibody Formation in a Patient With Mild Hemophilia A Blood, June 15, 1997; 89(12): 4371 - 4377. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Prescott, H. Nakai, E. L. Saenko, I. Scharrer, I. M. Nilsson, J. E. Humphries, D. Hurst, G. Bray, D. Scandella, and the Recombinate and Kogenate Study Groups The Inhibitor Antibody Response Is More Complex in Hemophilia A Patients Than in Most Nonhemophiliacs With Factor VIII Autoantibodies Blood, May 15, 1997; 89(10): 3663 - 3671. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Porta, S MacMillan, R Nagaraja, S Mumm, I Zucchi, G Pilia, S Maio, T Featherstone, and D Schlessinger 4.5-Mb YAC STS contig at 50-kb resolution, spanning Xq25 deletions in two patients with lymphoproliferative syndrome. Genome Res., January 1, 1997; 7(1): 27 - 36. [Abstract] [PDF] |
||||
![]() |
P. J. Lenting, J.-W. H. P. van de Loo, M.-J. S. H. Donath, J. A. van Mourik, and K. Mertens The Sequence Glu[IMAGE]-Lys[IMAGE] of Human Blood Coagulation Factor VIII Comprises a Binding Site for Activated Factor IX J. Biol. Chem., January 26, 1996; 271(4): 1935 - 1940. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Figueiredo and G. G. Brownlee cis-Acting Elements and Transcription Factors Involved in the Promoter Activity of the Human Factor VIII Gene J. Biol. Chem., May 19, 1995; 270(20): 11828 - 11838. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nogami, M. Shima, K. Hosokawa, M. Nagata, T. Koide, E. L. Saenko, I. Tanaka, M. Shibata, and A. Yoshioka Factor VIII C2 Domain Contains the Thrombin-binding Site Responsible for Thrombin-catalyzed Cleavage at Arg1689 J. Biol. Chem., August 11, 2000; 275(33): 25774 - 25780. [Abstract] [Full Text] [PDF] |
||||




